# EBUS-TBNA vs Acquire TBNB

> **NCT04200105** · NA · UNKNOWN · sponsor: **Royal Brompton & Harefield NHS Foundation Trust** · enrollment: 250 (estimated)

## Conditions studied

- Mediastinal Lymphadenopathy

## Interventions

- **DEVICE:** EBUS-TBNA
- **DEVICE:** Acquire TBNB

## Key facts

- **NCT ID:** NCT04200105
- **Lead sponsor:** Royal Brompton & Harefield NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-02
- **Primary completion:** 2021-03-01
- **Final completion:** 2021-08-01
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2019-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04200105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04200105, "EBUS-TBNA vs Acquire TBNB". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04200105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*